Recent studies, such as the one conducted by Silva Dos Santos J et al. [173], have also confirmed these mechanisms and demonstrated that kaempferol regulates specific pathways involved in AD progression (such as NF-κB, p38MAPK, and AKT) and achieves neuroprotection by regulating BDNF. The gene discussed is NFKB1; the disease is Alzheimer disease.